Related Experiment Videos
Sudden cardiac death in athletes
Peem Lorvidhaya1, Shoei K Stephen Huang
1Division of Cardiology, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Tex. 79430-9410, USA.
Cardiology
|January 10, 2004
Summary
Sudden cardiac death in athletes, though rare, is linked to congenital issues. Pre-participation screening is vital for identifying at-risk athletes and preventing these tragic events.
Area of Science:
- Cardiology
- Sports Medicine
- Preventive Cardiology
Background:
- Sudden cardiac death (SCD) in athletes is a significant concern, often linked to underlying congenital abnormalities.
- Athletes' capacity for intense physical activity can exacerbate underlying cardiac conditions, increasing SCD risk.
- Rising healthcare costs necessitate cost-effective screening methods for athletes.
Purpose of the Study:
- To review the causes of sudden cardiac death in athletes.
- To discuss current methods for detecting cardiac abnormalities in athletes.
- To outline pre-participation screening guidelines and emerging therapies for at-risk individuals.
Main Methods:
- Literature review of studies on sudden cardiac death in athletes.
- Analysis of congenital abnormalities associated with SCD in this population.
- Examination of current screening protocols and diagnostic tools.
- Overview of emerging therapeutic strategies.
Main Results:
- Congenital abnormalities are the primary identified causes of SCD in athletes.
- Pre-participation screening tests are crucial for identifying susceptible individuals.
- Cost-effective screening remains a challenge for widespread implementation.
- Various detection methods and emerging therapies show promise.
Conclusions:
- Understanding the causes and risk factors for SCD in athletes is essential.
- Effective pre-participation screening is key to reducing incidence.
- Continued research into cost-effective screening and novel therapies is warranted.